In view of these observations, exploring new anti-Alzheimer drugs with multiple potencies to concurrently inhibit the aggregation of Aβ and the activity of AChE will be a feasible strategy to combat AD [6,7]. This evidence concerns the gene ACHE and Alzheimer disease.